View Older Stories
-
Pain Therapeutics Reports Q3 2011 Financial Results
-
Barclays Maintains an 'Overweight' on PAREXEL (PRXL); Some Positives, But Still a Show Me
-
Standpoint Research Cuts Pfizer (PFE) to Hold Following Q3 Report
-
Pfizer (PFE) Tops the Street in Q3, Raises FY11 Outlook; Still Well-Positioned for Lipitor Expiration
-
Pfizer Reports Third-Quarter 2011 Results
-
Trading Radar for 11/01: Sirius (SIRI), Dollar Thrifty (DTG), Dunkin' (DNKN), Watson Pharma (WPI), Petsmart (PETS) Report
-
Alcoa (AA) to Start Q3 Earnings Season; Declining Aluminum Prices May Weigh
-
Jefferies Comments on Pfizer (PFE), Spin-off Followed by Acquisition of Bristo Myers (BMY) Offers 25% Earnings Growth
-
Jefferies Believes Pfizer's (PFE) PE Multiple Should Increase Due to Strong Pipeline Visibility
-
Notable 52-Week Highs and Lows of the Day 08/31: (BMY) (KO) (ABV) High; (OMN) (PSID) (BEAT) Low
-
Jefferies Upgrades Merck (MRK) to Buy
-
Pfizer (PFE) Q2 Results Reflect Exclusivity Losses; Reaffirms Guidance
-
Trading Radar for 08/02: Sirius XM (SIRI), Pfizer (PFE), CBS Corp. (CBS), Open Table (OPEN), MetroPCS (PCS), NYSE Euronext (NYX) Report
-
Q2 Preview: Divide and Conquer May Not Be Pfizer's (PFE) Best Option; Pipeline Looks Strong
-
Jefferies Downgrades PAREXEL International (PRXL) Two Notches to Underperform
-
Notable Mergers and Acquisitions of the Day 07/07: (APAC) (PFE) (EBAY)
-
Notable 52-Week Highs and Lows of the Day 06/28: (ACN) (SBUX) (ICGN) High; (ABAT) (ABH) (MMI) Low
-
Notable 52-Week Highs and Lows of the Day 06/24: (CBOU) (NLY) High; (DRRX) (STRI) (USU) Low
-
Unusual 11 Mid-Day Movers 06/24: (SUG) (YRCW) (NYNY) Higher; (PTIE) (DRRX) (STRI) Lower
-
Morning Movers 06/24: (NYNY) (SUG) (FTWR) Higher; (PTIE) (DRRX) (STRI) (SFSF) Lower
-
Unusual 11 Mid-Day Movers 06/20: (HRBN) (DEXO) (ACUR) Higher; (APWR) (HAFC) (CTFO) Lower
-
Barclays on U.S. Major Pharmaceuticals: Pipelines Revived? Making Strides in Oncology, Cardiology, and Virology
-
Jefferies maintains a 'Buy' on PAREXEL International (PRXL); Issues FY2012 Guidance; Affirms FY2011 Targets
-
Top 10 News Items 5/2-5/6: Osama bin Laden Killed by US Navy Seals; Bloodbath in Commodities; Jobs Report Better Than Expected
-
Notable ETF Movers of the Day 05/03: (VXX) (XLF) (FXE) Higher; (XLE) (MOO) (USO) Lower
-
Pfizer (PFE) Reports Flat Q1 Earnings, Sales; Traders Sell
-
Trading Radar for 05/03: Las Vegas Sands (LVS), Pfizer (PFE), CBS Corp. (CBS), First Solar (FSLR), Molson Coors (TAP) Report
-
A Rebounding U.S. Birth Rate or a Take-Out Will Drive Mead Johnson (MJN) Higher
-
Canaccord Genuity Morning Coffee on Pfizer (PFE): Selling The Farm?
-
Canaccord Genuity Morning Coffee on Walgreen (WAG) and Catalyst Health (CHSI): Breaking Up...Not So Hard To Do
-
Top 10 News Items 1/31-2/4: Jobs Report Adversely Impacted by Severe Winter Weather, Stocks Shrug at Unrest in Egypt, Q4 Earnings Season Winding Down
-
Pfizer (PFE) Is the Drug Wall Street Wants, Shares Jump 6%
-
Notable 52-Week Highs and Lows of the Day 02/01: PFE, MTW, CHK, BIDU High; OREX, TLB Low
-
Pfizer (PFE) Tops Street in Q4; Announced $5B Buyback, Mixed Guidance
-
Trading Radar for 02/01: United Parcel (UPS), BP Plc (BP), Electronic Arts (ERTS), MEMC (WFR) Report
-
Hedge Fund Investor Scores Big On Navistar (NAV), What Else Is He Buying?
-
Barclays on U.S. Major Pharmaceuticals: U.S. Major Pharma 2011 Outlook: A View Beyond the Cliff
-
Wells Fargo Starts Pfizer (PFE) at Outperform; Pipeline At Inflection, Dividend/Share Repo Provide Support
-
Alcoa (AA) Looks To Kick Off Q410 Earnings Season On the Right Foot
-
Top 10 News Items 12/6-12/10: Chinese IPO's On Fire!; S&P Makes A Plethora of Changes to Indices; AGL, Nicor Announce Major Deal In Nat-Gas Sector
-
Pfizer (PFE) Q3 Profit Falls 70% on Charges; Guides FY10
-
Trading Radar for 11/02: Pfizer (PFE), BP Plc (BP), Kellogg (K), Electronic Arts (ERTS), XL Group (XL) Report
-
Q3 Preview: Pfizer (PFE) Chugging Strong Into Earnings; M&A and Pipeline Key Focal Points (MRK, NVS)
-
Q3 Preview: Merck (MRK) Trading Strong Into Earnings, Looks to Nearly Double-Up Revs Y/Y (PFE, GSK, SNY)
-
Highlights From AAPL's Q4 Conference Call: Set New All-Time Records for Mac, iPhone and iPad Sales
-
Top 10 News Items 10/11-10/15: Fed Ready to Charge Ahead with QE2, Google Reports Blowout Quarter, Apple Crosses $300
